The signal transducer gp130 is shared by interleukin-6 family of haematopoietic and neurotrophic cytokines

Annals of Medicine

Volumn 29, Issue 1, 1997, Pages 63-72

  Taga, Tetsuya ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Cytokine; Cytokine receptor family; gp130; Interleukin 6; Signal transduction

Indexed keywords

CARDIOTROPHIN 1; CILIARY NEUROTROPHIC FACTOR; CYTOKINE; CYTOKINE RECEPTOR; GLYCOPROTEIN; GLYCOPROTEIN GP 130; INTERLEUKIN 11; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; LIGAND; MEMBRANE PROTEIN; ONCOSTATIN M; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR;

DIMERIZATION; HEMATOPOIETIC SYSTEM; NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SIGNAL TRANSDUCTION;

EID: 0031025673     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899708998744     Document Type: Review

References (88)

1. Bazan JF. Haemopoietic receptors and helical cytokines. Immunol Today 1990; 11: 350-4.
2. Taga T, Kishimoto T. Immune and hematopoietic cell regulation: cytokines and their receptors. Curr Opin Cell Biol 1990; 2: 174-80.
3. Taga T, Kishimoto T. Cytokine receptors and signal transduction. FASEB J 1992; 6: 3387-96.
4. Miyajima A, Kitamura T, Harada N, Yokota T, Arai K. Cytokine receptors and signal transduction. Annu Rev Immunol 1992; 10: 295-331.
5. Taniguchi T, Minami Y. The IL-2/IL-2 receptor system: a current overview. Cell 1993; 73: 5-8.
6. Kishimoto T, Taga T, Akira S. Cytokine signal transduction. Cell 1994; 76: 253-62.
7. Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 1990; 87: 6934-8.
8. Yamasaki K, Taga T, Hirata Y, et al. Cloning and expression of the human interleukin-6 (BSF-2/IFNb2) receptor. Science 1988; 241: 825-8.
9. Yawata H, Yasukawa K, Natsuka S, et al. Structure-function analysis of human IL-6 receptor: dissociation of amino acid residues required for IL-6-binding and for IL-6 signal transduction through gp130. EMBO J 1993; 12: 1705-12.
10. Patthy L. Homology of a domain of the growth hormone/ prolactin receptor family with type III modules of fibronectin. Cell 1990; 61: 13-4.
11. De Vos AM, Ultsch M, Kossiakoff AA. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 1992; 225: 306-12.
12. Taga T, Hibi M, Hirata Y, et al. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 1989; 58: 573-81.
13. Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 1990; 63: 1149-57.
14. Yang Y-C. Interleukin 11: an overview. Stem Cells (Dayt) 1993; 11: 474-86.
15. Hilton DJ, Gough NM. Leukemia inhibitory factor: a biological perspective. J Cell Biochem 1991; 46: 21-6.
16. Rose TM, Bruce AG. Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. Proc Natl Acad Sci USA 1991; 88: 8641-5.
17. Thoenen H. The changing scene of neurotropohic factors. Trends Neurosci 1991; 14: 165-70.
18. Ip NY, Yancopoulos GD. Ciliary neurotrophic factor and its receptor complex. Prog Growth Factor Res 1992; 4: 139-55.
19. Pennica D, King KL, Shaw KJ, et al. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci USA 1995; 92: 1142-6.
20. Kishimoto T, Akira S, Taga T. Interleukin-6 and its receptor: a paradigm for cytokines. Science 1992; 258: 593-7.
21. Schooltink H, Stoyan T, Roeb E, Heinrich PC, Rose-John S. Ciliary neurotrophic factor induces acute-phase protein expression in hepatocytes. FEBS Lett 1992; 314: 280-4.
22. Zhang XG, Gu JJ, Lu ZY, et al. Ciliary neurotrophic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. J Exp Med 1994; 179: 1337-42.
23. Conover JC, Ip NY, Poueymirou WT, et al. Ciliary neurotrophic factor maintains the pluripotentiality of embryonic stem cells. Development 1993; 119: 559-65.
24. Yoshida K, Chambers I, Nichols J, et al. Maintenance of the pluripotential phenotype of embryonic stem cells through direct activation of gp130 signalling pathways. Mech Dev 1994; 45: 163-71.
25. Wolf E, Kramer R, Polejaeva I, Thoenen H, Brem G. Efficient generation of chimaeric mice using embryonic stem cells after long-term culture in the presence of ciliary neurotrophic factor. Transgenic Res 1994; 3: 152-8.
26. Yamamori T, Fukada K, Aebersold R, Korsching S, Fann M-J, Patterson PH. The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor. Science 1989; 246: 1412-6.
27. Rao MS, Sun Y, Escary JL, et al. Leukemia inhibitory factor mediates an injury response but not a target-derived developmental transmitter switch in sympathetic neurons. Neuron 1993; 11: 1175-85.
28. Rao MS, Symes A, Malik N, Shoyab M, Fink JS, Landis SC. Oncostatin M regulates VIP expression in a human neuroblastoma cell line. Neuroreport 1992; 3: 865-8.
29. Pennica D, Shaw KJ, Swanson TA, et al. Cardiotrophin-1: biological activities and binding to the leukemia inhibitory facotor receptor/gp130 signaling complex. J Biol Chem 1995; 270: 10915-22.
30. Murakami M, Hibi M, Nakagawa N, et al. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 1993; 260: 1808-10.
31. Yin T, Taga T, Tsang ML, Yasukawa T, Kishimoto T, Yang Y-C. Involvement of interleukin-6 signal transducer gp130 in interleukin-11 mediated signal transduction. J Immunol 1993; 151: 2555-61.
32. Hilton DJ, Hilton AA, Raicevic A, et al. Cloning of a murine IL-11 receptor α chain; requirement for gp130 high affinity binding and signal transduction. EMBO J 1994; 13: 4765-75.
33. Gearing DP, Thut CJ, Vandenbos T, et al. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J 1991; 10: 2839-48.
34. Gearing DP, Comeau MR, Friend DJ, et al. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 1992; 255: 1434-7.
35. Liu J, Modrell B, Aruffo A, et al. Interleukin-6 signal transducer gp130 mediates oncostatin M signaling. J Biol Chem 1992; 267: 16763-6.
36. Thoma B, Bird TA, Friend DJ, Gearing DP, Dower SK. Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes. J Biol Chem 1994; 269: 6215-22.
37. Murakami-Mori K, Taga T, Kishimoto T, Nakamura S. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin m (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. J Clin Invest 1995; 96: 1319-27.
38. Ip NY, Nye SH, Boulton TG, et al. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 1992; 69: 1121-32.
39. Davis S, Aldrich TH, Stahl N, et al. LIFRβ and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science 1993; 260: 1805-8.
40. Taga T, Narazaki M, Yasukawa K, et al. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130. Proc Natl Acad Sci USA 1992; 89: 10998-1001.
41. Ware CB, Horowitz MC, Renshaw BR, et al. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 1995; 121: 1283-99.
42. Yoshida K, Taga T, Saito M, et al. Targeted disruption of gp130, a common signal transducer for IL-6-family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci USA 1996; 93: 407-11.
43. Fukunaga R, Seto Y, Mizushima S, Nagata S. Three different mRNAs encoding human granulocyte colony-stimulating factor receptor. Proc Natl Acad Sci USA 1990; 87: 8702-6.
44. Kobayashi M, Fitz M, Ryan M, et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989; 170: 827-45.
45. Gubler U, Chua AO, Schoenhaut DS, et al. Coexpression of two distinct genes is required to generate secreted bioactive cytoxic lymphocyte maturation factor. Proc Natl Acad Sci USA 1991; 88: 4143-7.
46. Wolf SF, Temple PA, Kobayashi M, et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 1991; 146: 3074-81.
47. Merberg DM, Wolf SF, Clark SC. Sequence similarity between NKSF and the IL-6/G-CSF family. Immunol Today 1992; 13: 77-8.
48. Gearing DP, Cosman D. Homology of the p40 subunit of natural killer cell stimulatory factor (NKSF) with the extracellular domain of the interleukin-6 receptor. Cell 1991; 66: 9-10.
49. Chua AO, Chizzonite R, Desai BB, et al. Expression cloning of a human IL-12 receptor component; a new member of the cytokine receptor superfamily with strong homology to gp130. J Immunol 1994; 153: 128-36.
50. Tartaglia LA, Dembski M, Weng X, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995; 83: 1263-71.
51. Lee GH, Proenca R, Montez JM, et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996; 379: 632-5.
52. Kopf M, Baumann H, Freer G, et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994; 368: 339-42.
53. Stewart CL, Kaspar P, Brunet LJ, et al. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992; 359: 76-9.
54. Masu Y, Wolf E, Holtmann B, Sendtner M, Brem G, Thoenen H. Disruption of the CNTF gene results in motor neuron degeneration. Nature 1993; 365: 27-32.
55. Poli V, Balena R, Fattori E, et al. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 1994; 13: 1189-96.
56. Banner LR, Patterson PH. Major changes in the expression of the mRNAs for cholinergic differentiation factor/ leukemia inhibitory factor and its receptor after injury to adult peripheral nerves and ganglia. Proc Natl Acad Sci USA 1994; 91: 7109-13.
57. Li M, Sendtner M, Smith A. Essential function of LIF receptor in motor neurons. Nature 1995; 378: 724-7.
58. DeChiara TM, Vejsada R, Poueymirou WT, et al. Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth. Cell 1995; 83: 313-22.
59. Hirota H, Yoshida K, Kishimoto T, Taga T. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci USA 1995; 92: 4862-6.
60. Saito M, Yoshida K, Hibi M, Taga T, Kishimoto T. Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo. J Immunol 1992; 148: 4066-71.
61. Hirota H, Kiyama H, Kishimoto T, Taga T. Accelerated nerve regeneration in mice by upregulated expression of IL-6 and IL-6 receptor after trauma. J Exp Med (in press).
62. Davis S, Aldrich TH, Valenzuela DM, et al. The receptor for ciliary neurotrophic factor. Science 1991; 253: 59-63.
63. Narazaki M, Yasukawa K, Saito T, et al. Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood 1993; 82: 1220-6.
64. Davis S, Aldrich TH, Ip NY, et al. Released form of CNTF receptor a component as a soluble mediator of CNTF responses. Science 1993; 259: 1736-9.
65. Tamura T, Udagawa N, Takahashi N, et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6. Proc Natl Acad Sci USA 1993; 90: 11924-8.
66. Gaillard JP, Bataille R, Brailly H, et al. Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy. Eur J Immunol 1993; 23: 820-4.
67. De Benedetti F, Massa M, Pignatti P, Albani S, Novick D, Martini A. Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest 1994; 93: 2114-9.
68. Lutticken C, Wegenka UM, Yuan J, et al. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science 1994; 263: 89-92.
69. Stahl N, Boulton TG, Farruggella T, et al. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 β receptor components. Science 1994; 263: 92-5.
70. Stahl N, Farruggella TJ, Boulton TG, Zhong Z, Darnell JEJr, Yancopoulos GD. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 1995; 267: 1349-53.
71. Narazaki M, Witthuhn BA, Yoshida K, et al. Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130. Proc Natl Acad Sci USA 1994; 91: 2285-9.
72. Murakami M, Narazaki M, Hibi M, et al. Critical cytoplasmic region of the IL-6 signal transducer, gp130, is conserved in the cytokine receptor family. Proc Natl Acad Sci USA 1991; 88: 11349-53.
73. Tanner JW, Chen W, Young RL, Longmore GD. The conserved box 1 motif of cytokine receptors is required for association with JAK kinases. J Biol Chem 1995; 270: 6523-30.
74. Ihle JN, Kerr I. Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet 1995; 11: 69-74.
75. Darnel JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264: 1415-21.
76. Akira S, Nishio Y, Inoue M, et al. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 1994; 77: 63-71.
77. Zhon Z, Wen Z, Darnell JE Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994; 264: 95-8.
78. Zhang X, Blenis J, Li H-C, Schindler C, Chen-Kiang S. Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 1995; 267: 1990-4.
79. Boulton TG, Zhong Z, Wen Z, Darnell JE Jr, Stahl N, Yancopoulos GD. STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase. Proc Natl Acad Sci USA 1995; 92: 6915-9.
80. Wen Z, Zhong Z, Darnell JE Jr. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 1995; 82: 241-50.
81. Satoh T, Nakafuku M, Kaziro Y. Function of Ras as a molecular switch in signal transduction. J Biol Chem 1992; 267: 24149-52.
82. Boulton TG, Stahl N, Yancopoulos GD. Ciliary neurotrophic factor/leukemia inhibitory factor/interleukin 6/ oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors. J Biol Chem 1994; 269: 11648-55.
83. Daeipour M, Kumar G, Amaral MC. Recombinant IL-6 activates p42 and p44 mitogen-activated protein kinases in the IL-6 responsive B cell line, AF-10. J Immunol 1993; 150: 4743-53.
84. Baumann H, Prowse KR, Marinkovic S, Won KA, Jahreis GP. Stimulation of hepatic acute phase response by cytokines and glucocorticoids. Ann NY Acad Sci 1989; 557: 280-96.
85. Akira S, Kishimoto T. IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev 1992; 127: 25-50.
86. Wegenka UM, Bushmann J, Lütticken C, Heinrich PC, Horn F. Acute-phase response (actor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleuin-6 at the posttranslation level. Mol Cell Biol 1993; 13: 276-88.
87. Isshiki H, Akira S, Tanabe O, et al. Constitutive and IL-1 inducible factors interact with the IL-1 responsive element in the IL-6 gene. Mol Cell Biol 1990; 10: 2757-64.
88. Nakajima T, Kinoshita S, Sasagawa T, et al. Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL-6. Proc Natl Acad Sci USA 1993; 90: 2207-11.